These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7327483)

  • 21. Testing computational toxicology models with phytochemicals.
    Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
    Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of the guppy, Poecilia reticulata, in carcinogenicity testing: special advantages and problems.
    Zimmerer EJ
    Natl Cancer Inst Monogr; 1984 May; 65():59-64. PubMed ID: 6462199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP.
    Sasaki YF; Fujikawa K; Ishida K; Kawamura N; Nishikawa Y; Ohta S; Satoh M; Madarame H; Ueno S; Susa N; Matsusaka N; Tsuda S
    Mutat Res; 1999 Mar; 440(1):1-18. PubMed ID: 10095124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis.
    Barrett JC; Hesterberg TW; Thomassen DG
    Pharmacol Rev; 1984 Jun; 36(2 Suppl):53S-70S. PubMed ID: 6473503
    [No Abstract]   [Full Text] [Related]  

  • 25. A survey of the Predictive Toxicology Challenge 2000-2001.
    Helma C; Kramer S
    Bioinformatics; 2003 Jul; 19(10):1179-82. PubMed ID: 12835259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "IARC group 2B Carcinogens" reported in cigarette mainstream smoke.
    Smith CJ; Perfetti TA; Mullens MA; Rodgman A; Doolittle DJ
    Food Chem Toxicol; 2000 Sep; 38(9):825-48. PubMed ID: 10930704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of transgenic mice in carcinogenicity hazard assessment.
    Jacobson-Kram D; Sistare FD; Jacobs AC
    Toxicol Pathol; 2004; 32 Suppl 1():49-52. PubMed ID: 15209403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. "IARC Group 2B carcinogens" reported in cigarette mainstream smoke.
    Smith CJ; Perfetti TA; Rumple MA; Rodgman A; Doolittle DJ
    Food Chem Toxicol; 2001 Feb; 39(2):183-205. PubMed ID: 11267712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis and interpretation of data from carcinogenicity and toxicity studies in animals.
    Reuber MD
    Sci Total Environ; 1983 Jul; 29(1-2):1-17. PubMed ID: 6612321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can systems toxicology identify common biomarkers of non-genotoxic carcinogenesis?
    Plant N
    Toxicology; 2008 Dec; 254(3):164-9. PubMed ID: 18674585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Syrian hamster embryo cells transformation assay identifies efficiently nongenotoxic carcinogens, and can contribute to alternative, integrated testing strategies.
    Benigni R; Bossa C; Tcheremenskaia O; Battistelli CL; Giuliani A
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Feb; 779():35-8. PubMed ID: 25813724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expanding role of predictive toxicology: an update on the (Q)SAR models for mutagens and carcinogens.
    Benigni R; Netzeva TI; Benfenati E; Bossa C; Franke R; Helma C; Hulzebos E; Marchant C; Richard A; Woo YT; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(1):53-97. PubMed ID: 17365342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of transgenic animals for carcinogenicity testing: considerations and implications for risk assessment.
    Gulezian D; Jacobson-Kram D; McCullough CB; Olson H; Recio L; Robinson D; Storer R; Tennant R; Ward JM; Neumann DA
    Toxicol Pathol; 2000; 28(3):482-99. PubMed ID: 10862569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Issues in carcinogenicity testing: dose selection.
    Haseman JK
    Fundam Appl Toxicol; 1985 Feb; 5(1):66-78. PubMed ID: 3886467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The science and practice of carcinogen identification and evaluation.
    Cogliano VJ; Baan RA; Straif K; Grosse Y; Secretan MB; El Ghissassi F; Kleihues P
    Environ Health Perspect; 2004 Sep; 112(13):1269-74. PubMed ID: 15345338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IARC classification system for carcinogens.
    Vainio H; Shuker L; Wilbourn J; Tomatis L
    Am J Ind Med; 1991; 20(6):819-22. PubMed ID: 1805620
    [No Abstract]   [Full Text] [Related]  

  • 37. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics.
    Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L
    Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening assays for carcinogenic agents and mixtures: an appraisal based on data in the IARC Monograph series.
    Bartsch H; Malaveille C
    IARC Sci Publ; 1990; (104):65-74. PubMed ID: 2228144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Threshold of Toxicological Concern (TTC)--challenges and approaches.
    Dewhurst I; Renwick AG
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):168-77. PubMed ID: 22714052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer.
    Huff J
    Int J Occup Environ Health; 2002; 8(3):249-70. PubMed ID: 12358081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.